Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 586.36% and ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

Insulet (PODD – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Patrick Wood ...

Cardiovascular conditions like coronary artery disease, congenital heart disorders, and abnormal heartbeats can cause you to ...

Hims & Hers Health (HIMS 5.09%) has built its brand up in recent years by focusing on offering its customers products related ...

Perhaps no other disease has the writing on the wall as much as warnings for heart disease. For years now, we’ve been asked ...

The agency took the unusual step based on what it called a severely lacking response by sheriff’s deputies to Keith Galen ...

We recently compiled a list of the 7 Best Big Company Stocks to Buy Now. In this article, we are going to take a look at ...

Mega-cap stocks—major technology companies to be precise—continued to drive a disproportionate share of the total US stock ...

Are you one of the millions of people unknowingly living with high blood pressure? You’re not alone. Nearly half of American ...

Wall Street analysts are betting on a 2027 list that will include Novo Nordisk's (NVO) blockbuster Ozempic for diabetes and have a limited impact on Big Pharma. Other possible 2027 candidates ...

Wall Street analysts are betting on a 2027 list that will include Novo Nordisk's blockbuster (NOVOb.CO), opens new tab Ozempic for diabetes and have a limited impact on Big Pharma. The drugs ...